News Coverage 10.17.19 By: Adam Feuerstein Share on Twitter Share on Facebook Share on LinkedIn Sean Parker, billionaire and philanthropist, gets an immunotherapy company off the ground Related Announcement PICI Network Researchers to Present #SITC22 Announcement Dana-Farber and Gladstone Institutes Join PICI Network Announcement, Our Impact Parker Institute Researchers Featured at #CICON22